Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	7.93	12.91	11.96
Graham Fair Price	0.00	6.11	6.11
PEG	inf	0.00	0.02
Price/Book	6.58	4.73	4.44
Price/Cash Flow	-6.58	-124.55	-116.86
Prices/Earnings	6.58	4.70	4.41
Price/Sales	6.58	1.67	1.57
Price/FCF	-6.58	-124.55	-116.86
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.19	0.19
Operating Margin	0.00	0.11	0.11
ROA	0.00	0.07	0.07
ROE	0.25	0.25	0.00
ROIC	0.23	0.23	-0.73
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.22	0.06	247.11
Dividends QOQ	< 0.005	0.00	inf
EBIT QOQ	2.35	0.00	inf
EPS QOQ	2.25	0.00	inf
FCF QOQ	-1.19	0.00	inf
Revenue QOQ	0.36	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.46	0.46	0.00
Days Sales Outstanding (DSO)	8.00	8.00	0.00
Inventory Turnover	197.46	197.46	0.00
Debt/Capitalization	0.03	0.04	20.76
Quick Ratio	0.35	0.35	< 0.005
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2.57	2.57	0.00
Cash	1.78	1.78	< 0.005
Capex	-0.03	-0.03	0.00
Free Cash Flow	-0.10	-0.10	0.00
Revenue	7.28	7.28	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.25	1.25	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.09	-2.06	1.15
Naive Interpretation	Member

06 - Financial Health · Weak

Rating